ANN ARBOR, Mich., Dec. 21, 2022 (GLOBE NEWSWIRE) — Akadeum Life Sciences, Inc., a global leader in buoyancy-based cell separation technology, announces their Microbubble Leukopak Human T Cell Isolation research-use-only kit that resulted from successful external user data with early adopters. Akadeum’s T cell isolation kit is an industry first to incorporate Buoyancy Activated Cell Sorting (BACS™) Separation Tubes. This novel product directly targets and solves previous workflow challenges for biospecimen providers and cell and gene therapy (C>) researchers, by outperforming current industry standards in speed, performance, and throughput.
While cell and gene therapy research is groundbreaking and critical to future therapeutics, the process is often dependent on large quantities of highly pure cells isolated from leukopaks. For example, the isolation of cells from leukopaks is a critical first step in CAR T therapy and associated research workflows. However, current methods are tedious, labor-intensive, and inefficient, taking too long and leaving a lot to be desired when it comes to maximizing the recovery of the target cells.
Read more here.